-
1
-
-
84865701980
-
Aortic stiffness, blood pressure progression, and incident hypertension
-
Kaess BM, Rong J, Larson MG, et al. Aortic stiffness, blood pressure progression, and incident hypertension. JAMA. 2012;308:875-881.
-
(2012)
JAMA.
, vol.308
, pp. 875-881
-
-
Kaess, B.M.1
Rong, J.2
Larson, M.G.3
-
2
-
-
41149157083
-
Pulse wave velocity is an independent predictor of the longitudinal increase in systolic blood pressure and of incident hypertension in the Baltimore Longitudinal Study of Aging
-
Najjar SS, Scuteri A, Shetty V, et al. Pulse wave velocity is an independent predictor of the longitudinal increase in systolic blood pressure and of incident hypertension in the Baltimore Longitudinal Study of Aging. J Am Coll Cardiol. 2008;51:1377-1383.
-
(2008)
J Am Coll Cardiol.
, vol.51
, pp. 1377-1383
-
-
Najjar, S.S.1
Scuteri, A.2
Shetty, V.3
-
3
-
-
84880015206
-
2013 ESH/ESC Guidelines for the management of arterial hypertension
-
The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
-
The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). 2013 ESH/ESC Guidelines for the management of arterial hypertension. J Hypertens. 2013;31:1281-1357.
-
(2013)
J Hypertens.
, vol.31
, pp. 1281-1357
-
-
-
4
-
-
0031903105
-
Endothelial function and common carotid artery wall thickening in patients with essential hypertension
-
Ghiadoni L, Taddei S, Virdis A, et al. Endothelial function and common carotid artery wall thickening in patients with essential hypertension. Hypertension. 1998;32:25-32.
-
(1998)
Hypertension.
, vol.32
, pp. 25-32
-
-
Ghiadoni, L.1
Taddei, S.2
Virdis, A.3
-
5
-
-
12844253061
-
Endothelial function: cardiac events
-
Lerman A, Zeiher AM. Endothelial function: cardiac events. Circulation. 2005;111:363-368.
-
(2005)
Circulation.
, vol.111
, pp. 363-368
-
-
Lerman, A.1
Zeiher, A.M.2
-
6
-
-
77954814318
-
Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis
-
Vlachopoulos C, Aznaouridis K, O'Rourke MF, et al. Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis. Eur Heart J. 2010;31:1865-1871.
-
(2010)
Eur Heart J.
, vol.31
, pp. 1865-1871
-
-
Vlachopoulos, C.1
Aznaouridis, K.2
O'Rourke, M.F.3
-
7
-
-
33645518432
-
Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study
-
Williams B, Lacy PS, Thom SM, et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation. 2006;113:1213-1225.
-
(2006)
Circulation.
, vol.113
, pp. 1213-1225
-
-
Williams, B.1
Lacy, P.S.2
Thom, S.M.3
-
8
-
-
67649586928
-
Central or peripheral systolic or pulse pressure: which best relates to target organs and future mortality?
-
Wang KL, Cheng HM, Chuang SY, et al. Central or peripheral systolic or pulse pressure: which best relates to target organs and future mortality? J Hypertens. 2009;27:461-467.
-
(2009)
J Hypertens.
, vol.27
, pp. 461-467
-
-
Wang, K.L.1
Cheng, H.M.2
Chuang, S.Y.3
-
9
-
-
77149162035
-
Wave reflection and arterial stiffness in the prediction of 15-year all-cause and cardiovascular mortalities: a community-based study
-
Wang KL, Cheng HM, Sung SH, et al. Wave reflection and arterial stiffness in the prediction of 15-year all-cause and cardiovascular mortalities: a community-based study. Hypertension. 2010;55:799-805.
-
(2010)
Hypertension.
, vol.55
, pp. 799-805
-
-
Wang, K.L.1
Cheng, H.M.2
Sung, S.H.3
-
10
-
-
84866293547
-
Central blood pressure and pulse wave velocity: relationship to target organ damage and cardiovascular morbidity-mortality in diabetic patients or metabolic syndrome. An observational prospective study. LOD-DIABETES study protocol
-
Gomez-Marcos MA, Recio-Rodriguez JI, Rodriguez-Sanchez E, et al. Central blood pressure and pulse wave velocity: relationship to target organ damage and cardiovascular morbidity-mortality in diabetic patients or metabolic syndrome. An observational prospective study. LOD-DIABETES study protocol. BMC Public Health. 2010;10:143.
-
(2010)
BMC Public Health.
, vol.10
, pp. 143
-
-
Gomez-Marcos, M.A.1
Recio-Rodriguez, J.I.2
Rodriguez-Sanchez, E.3
-
11
-
-
70349312455
-
Central aortic stiffness is increased in patients with heart failure and preserved ejection fraction
-
Desai AS, Mitchell GF, Fang JC, Creager MA. Central aortic stiffness is increased in patients with heart failure and preserved ejection fraction. J Card Fail. 2009;15:658-664.
-
(2009)
J Card Fail.
, vol.15
, pp. 658-664
-
-
Desai, A.S.1
Mitchell, G.F.2
Fang, J.C.3
Creager, M.A.4
-
12
-
-
0025218934
-
Nitroglycerine has more favourable effects on left ventricular after load than is apparent from measurement of pressure in a peripheral artery
-
Kelly MP, Gibbs HH, O'Rourke M, et al. Nitroglycerine has more favourable effects on left ventricular after load than is apparent from measurement of pressure in a peripheral artery. Eur Heart J. 1990;11:138-144.
-
(1990)
Eur Heart J.
, vol.11
, pp. 138-144
-
-
Kelly, M.P.1
Gibbs, H.H.2
O'Rourke, M.3
-
13
-
-
0029005591
-
Different effects of fosinopril and atenolol on wave reflections in hypertensive patients
-
Chen C-H, Ting C-T, Lin S-J, et al. Different effects of fosinopril and atenolol on wave reflections in hypertensive patients. Hypertension. 1995;25:1034-1041.
-
(1995)
Hypertension.
, vol.25
, pp. 1034-1041
-
-
Chen, C.-H.1
Ting, C.-T.2
Lin, S.-J.3
-
14
-
-
0035687988
-
Different aortic reflection wave responses following long-term angiotensin-converting enzyme inhibition and beta-blocker in essential hypertension
-
Pannier BM, Guerin AP, Marchais SJ, London G. Different aortic reflection wave responses following long-term angiotensin-converting enzyme inhibition and beta-blocker in essential hypertension. Clin Exp Pharmacol Physiol. 2001;28:1074-1077.
-
(2001)
Clin Exp Pharmacol Physiol.
, vol.28
, pp. 1074-1077
-
-
Pannier, B.M.1
Guerin, A.P.2
Marchais, S.J.3
London, G.4
-
15
-
-
0035569613
-
Vasoactive drugs influence aortic augmentation index independently of pulse wave velocity in healthy men
-
Kelly RP, Millasseau SC, Ritter JM, Chowienczyk PJ. Vasoactive drugs influence aortic augmentation index independently of pulse wave velocity in healthy men. Hypertension. 2001;37:1429-1433.
-
(2001)
Hypertension.
, vol.37
, pp. 1429-1433
-
-
Kelly, R.P.1
Millasseau, S.C.2
Ritter, J.M.3
Chowienczyk, P.J.4
-
16
-
-
11144307813
-
Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment
-
Schiffrin EL. Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment. Am J Hypertens. 2004;17:1192-1200.
-
(2004)
Am J Hypertens.
, vol.17
, pp. 1192-1200
-
-
Schiffrin, E.L.1
-
17
-
-
0028017546
-
Effect of captopril and enalapril on endothelial function in hypertensive patients
-
Creager MA, Roddy MA. Effect of captopril and enalapril on endothelial function in hypertensive patients. Hypertension. 1994;24:499-505.
-
(1994)
Hypertension.
, vol.24
, pp. 499-505
-
-
Creager, M.A.1
Roddy, M.A.2
-
18
-
-
0029989647
-
Effects of cilazapril on vascular structure and function in essential hypertension
-
Kiowski W, Linder L, Nuesch R, Martina B. Effects of cilazapril on vascular structure and function in essential hypertension. Hypertension. 1996;1:371-376.
-
(1996)
Hypertension.
, vol.1
, pp. 371-376
-
-
Kiowski, W.1
Linder, L.2
Nuesch, R.3
Martina, B.4
-
19
-
-
0031956678
-
Effects of angiotensin converting enzyme inhibition on endothelium-dependent vasodilatation in essential hypertensive patients
-
Taddei S, Virdis A, Ghiadoni L, et al. Effects of angiotensin converting enzyme inhibition on endothelium-dependent vasodilatation in essential hypertensive patients. J Hypertens. 1998;16:447-456.
-
(1998)
J Hypertens.
, vol.16
, pp. 447-456
-
-
Taddei, S.1
Virdis, A.2
Ghiadoni, L.3
-
20
-
-
0033983241
-
Effect of the angiotensin II type 1 receptor blocker candesartan on endothelial function in patients with essential hypertension
-
Ghiadoni L, Virdis A, Magagna A, et al. Effect of the angiotensin II type 1 receptor blocker candesartan on endothelial function in patients with essential hypertension. Hypertension. 2000;2:501-506.
-
(2000)
Hypertension.
, vol.2
, pp. 501-506
-
-
Ghiadoni, L.1
Virdis, A.2
Magagna, A.3
-
21
-
-
0037305368
-
Effect of AT1 receptor blockade on endothelial function in essential hypertension
-
Klingbeil AU, John S, Schneider MP, et al. Effect of AT1 receptor blockade on endothelial function in essential hypertension. Am J Hypertens. 2003;16:123-128.
-
(2003)
Am J Hypertens.
, vol.16
, pp. 123-128
-
-
Klingbeil, A.U.1
John, S.2
Schneider, M.P.3
-
22
-
-
0033574249
-
A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group
-
Levey AS, Bosh JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med. 1999;130:461-470.
-
(1999)
Ann Intern Med.
, vol.130
, pp. 461-470
-
-
Levey, A.S.1
Bosh, J.P.2
Lewis, J.B.3
-
23
-
-
1442353591
-
Peripheral arterial tonometry: a diagnostic method for detection of myocardial ischemia induced during mental stress tests: a pilot study
-
Goor DA, Sheffy J, Schnall RP, et al. Peripheral arterial tonometry: a diagnostic method for detection of myocardial ischemia induced during mental stress tests: a pilot study. Clin Cardiol. 2004;27:137-141.
-
(2004)
Clin Cardiol.
, vol.27
, pp. 137-141
-
-
Goor, D.A.1
Sheffy, J.2
Schnall, R.P.3
-
24
-
-
0038239542
-
Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease
-
Bonetti PO, Barsness GW, Keelan PC, et al. Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease. J Am Coll Cardiol. 2003;41:1761-1768.
-
(2003)
J Am Coll Cardiol.
, vol.41
, pp. 1761-1768
-
-
Bonetti, P.O.1
Barsness, G.W.2
Keelan, P.C.3
-
26
-
-
0033847201
-
Peripheral arterial tonometry: a novel and sensitive non-invasive monitor of brief arousals during sleep
-
Lavie P, Shlitner A, Sheffy J, Schnall RP. Peripheral arterial tonometry: a novel and sensitive non-invasive monitor of brief arousals during sleep. Isr Med Assoc J. 2000;2:246-247.
-
(2000)
Isr Med Assoc J.
, vol.2
, pp. 246-247
-
-
Lavie, P.1
Shlitner, A.2
Sheffy, J.3
Schnall, R.P.4
-
27
-
-
9644287891
-
Effect of long-term hormone replacement therapy on coronary endothelial function in postmenopausal women
-
Halligan SC, Murtagh B, Lennon RJ, et al. Effect of long-term hormone replacement therapy on coronary endothelial function in postmenopausal women. Mayo Clin Proc. 2004;79:1514-1520.
-
(2004)
Mayo Clin Proc.
, vol.79
, pp. 1514-1520
-
-
Halligan, S.C.1
Murtagh, B.2
Lennon, R.J.3
-
28
-
-
9644265239
-
Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia
-
Bonetti PO, Pumper GM, Higano ST, et al. Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J Am Coll Cardiol. 2004;44:2137-2141.
-
(2004)
J Am Coll Cardiol.
, vol.44
, pp. 2137-2141
-
-
Bonetti, P.O.1
Pumper, G.M.2
Higano, S.T.3
-
29
-
-
76349122414
-
Signal transduction of the (pro)renin receptor as a novel therapeutic target for preventing end-organ damage
-
Funke-Kaiser H, Zollmann FS, Schefe JH, et al. Signal transduction of the (pro)renin receptor as a novel therapeutic target for preventing end-organ damage. Hypertens Res. 2010;33:98-104.
-
(2010)
Hypertens Res.
, vol.33
, pp. 98-104
-
-
Funke-Kaiser, H.1
Zollmann, F.S.2
Schefe, J.H.3
-
30
-
-
79551560598
-
Renin and prorenin receptor in hypertension: what's new?
-
Nguyen G. Renin and prorenin receptor in hypertension: what's new? Curr Hypertens Rep. 2011;13:79-85.
-
(2011)
Curr Hypertens Rep.
, vol.13
, pp. 79-85
-
-
Nguyen, G.1
-
31
-
-
35848948398
-
Prorenin is the endogenous agonist of the (pro)renin receptor. Binding kinetics of renin and prorenin in rat vascular smooth muscle cells overexpressing the human (pro) renin receptor
-
Batenburg WW, Krop M, Garrelds IM, et al. Prorenin is the endogenous agonist of the (pro)renin receptor. Binding kinetics of renin and prorenin in rat vascular smooth muscle cells overexpressing the human (pro) renin receptor. J Hypertens. 2007;25:2441-2453.
-
(2007)
J Hypertens.
, vol.25
, pp. 2441-2453
-
-
Batenburg, W.W.1
Krop, M.2
Garrelds, I.M.3
-
32
-
-
46449118638
-
Effects of aliskiren on blood pressure, albuminuria, and (pro)renin receptor expression in diabetic TG(mRen-2)27 rats
-
Feldman DL, Jin L, Xuan H, et al. Effects of aliskiren on blood pressure, albuminuria, and (pro)renin receptor expression in diabetic TG(mRen-2)27 rats. Hypertension. 2008;52:130-136.
-
(2008)
Hypertension.
, vol.52
, pp. 130-136
-
-
Feldman, D.L.1
Jin, L.2
Xuan, H.3
-
33
-
-
30944465223
-
Receptor-mediated actions of renin and prorenin
-
Oliver JA. Receptor-mediated actions of renin and prorenin. Kidney Int. 2006;69:13-15.
-
(2006)
Kidney Int.
, vol.69
, pp. 13-15
-
-
Oliver, J.A.1
-
34
-
-
30944469631
-
Renin increases mesangial cell TGF-1 and matrix proteins through receptor-mediated, Ang II-independent mechanisms
-
Huang Y, Wongamornthan S, Kasting J, et al. Renin increases mesangial cell TGF-1 and matrix proteins through receptor-mediated, Ang II-independent mechanisms. Kidney Int. 2006;69:105-113.
-
(2006)
Kidney Int.
, vol.69
, pp. 105-113
-
-
Huang, Y.1
Wongamornthan, S.2
Kasting, J.3
-
35
-
-
0029853814
-
Specific receptor binding of renin on human mesangial cells in culture increases plasminogen activator inhibitor-1 antigen
-
Nguyen G, Delarue F, Berrou J, et al. Specific receptor binding of renin on human mesangial cells in culture increases plasminogen activator inhibitor-1 antigen. Kidney Int. 1996;50:1897-1903.
-
(1996)
Kidney Int.
, vol.50
, pp. 1897-1903
-
-
Nguyen, G.1
Delarue, F.2
Berrou, J.3
-
36
-
-
0036266596
-
Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin
-
Nguyen G, Delarue F, Burckle C, et al. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest. 2002;109:1417-1427.
-
(2002)
J Clin Invest.
, vol.109
, pp. 1417-1427
-
-
Nguyen, G.1
Delarue, F.2
Burckle, C.3
-
37
-
-
75149139972
-
Effect of direct renin inhibition on renal hemodynamic function, arterial stiffness, and endothelial function in humans with uncomplicated type 1 diabetes: a pilot study
-
Cherney DZ, Lai V, Scholey JW, et al. Effect of direct renin inhibition on renal hemodynamic function, arterial stiffness, and endothelial function in humans with uncomplicated type 1 diabetes: a pilot study. Diabetes Care. 2010;33:361-365.
-
(2010)
Diabetes Care.
, vol.33
, pp. 361-365
-
-
Cherney, D.Z.1
Lai, V.2
Scholey, J.W.3
-
38
-
-
79955621477
-
Peripheral and central blood pressure responses of combination aliskiren / hydrochlorothiazide and amlodipine monotherapy in African American patients with stage 2 hypertension: the ATLAAST trial
-
Ferdinand KC, Pool J, Weitzman R, et al. Peripheral and central blood pressure responses of combination aliskiren / hydrochlorothiazide and amlodipine monotherapy in African American patients with stage 2 hypertension: the ATLAAST trial. J Clin Hypertens (Greenwich). 2011;13:366-375.
-
(2011)
J Clin Hypertens (Greenwich).
, vol.13
, pp. 366-375
-
-
Ferdinand, K.C.1
Pool, J.2
Weitzman, R.3
-
39
-
-
85027933664
-
Effects of aliskiren-based therapy on ambulatory blood pressure profile, central hemodynamics, and arterial stiffness in nondiabetic mild to moderate hypertensive patients
-
Kanaoka T, Tamura K, Ohsawa M, et al. Effects of aliskiren-based therapy on ambulatory blood pressure profile, central hemodynamics, and arterial stiffness in nondiabetic mild to moderate hypertensive patients. J Clin Hypertens (Greenwich). 2012;14:522-529.
-
(2012)
J Clin Hypertens (Greenwich).
, vol.14
, pp. 522-529
-
-
Kanaoka, T.1
Tamura, K.2
Ohsawa, M.3
-
40
-
-
84877318986
-
Effect of aliskiren on arterial stiffness, compared with ramipril in patients with mild to moderate essential hypertension
-
Guo JQ, Wang HY, SUN NL. Effect of aliskiren on arterial stiffness, compared with ramipril in patients with mild to moderate essential hypertension. Chin Med J. 2013;126:1242-1246.
-
(2013)
Chin Med J.
, vol.126
, pp. 1242-1246
-
-
Guo, J.Q.1
Wang, H.Y.2
Sun, N.L.3
-
41
-
-
73949092078
-
Dynamic observation of mechanically-injured mouse femoral artery reveals an anti-inflammatory effect of renin inhibitor
-
Ino J, Kojima C, Osaka M, et al. Dynamic observation of mechanically-injured mouse femoral artery reveals an anti-inflammatory effect of renin inhibitor. Arterioscler Thromb Vasc Biol. 2009;29:1858-1863.
-
(2009)
Arterioscler Thromb Vasc Biol.
, vol.29
, pp. 1858-1863
-
-
Ino, J.1
Kojima, C.2
Osaka, M.3
-
42
-
-
52049097072
-
Renin inhibitor aliskiren improves impaired nitric oxide bioavailability and protects against atherosclerotic changes
-
Imanishi T, Tsujioka H, Ikejima H, et al. Renin inhibitor aliskiren improves impaired nitric oxide bioavailability and protects against atherosclerotic changes. Hypertension. 2008;52:563-572.
-
(2008)
Hypertension.
, vol.52
, pp. 563-572
-
-
Imanishi, T.1
Tsujioka, H.2
Ikejima, H.3
-
43
-
-
40549106756
-
Renin inhibition reduces hypercholesterolemia-induced atherosclerosis in mice
-
Lu H, Rateri DL, Feldman DL, et al. Renin inhibition reduces hypercholesterolemia-induced atherosclerosis in mice. J Clin Invest. 2008;118:984-993.
-
(2008)
J Clin Invest.
, vol.118
, pp. 984-993
-
-
Lu, H.1
Rateri, D.L.2
Feldman, D.L.3
-
44
-
-
42349086752
-
Renin inhibition by aliskiren prevents atherosclerosis progression: comparison with irbesartan, atenolol, and amlodipine
-
Nussberger J, Aubert JF, Bouzourene K, et al. Renin inhibition by aliskiren prevents atherosclerosis progression: comparison with irbesartan, atenolol, and amlodipine. Hypertension. 2008;51:1306-1311.
-
(2008)
Hypertension.
, vol.51
, pp. 1306-1311
-
-
Nussberger, J.1
Aubert, J.F.2
Bouzourene, K.3
-
45
-
-
83455178367
-
Aliskiren inhibits atherosclerosis development and improves plaque stability in APOE*3Leiden.CETP transgenic mice with or without treatment with atorvastatin
-
Kuhnast S, van der Hoorn JW, van den Hoek AM, et al. Aliskiren inhibits atherosclerosis development and improves plaque stability in APOE*3Leiden.CETP transgenic mice with or without treatment with atorvastatin. J Hypertens. 2012;30:107-116.
-
(2012)
J Hypertens.
, vol.30
, pp. 107-116
-
-
Kuhnast, S.1
van der Hoorn, J.W.2
van den Hoek, A.M.3
-
46
-
-
84863588651
-
Effect of aliskiren treatment on endothelium-dependent vasodilation and aortic stiffness in essential hypertensive patients
-
Virdis A, Ghiadoni L, Qasem AA, et al. Effect of aliskiren treatment on endothelium-dependent vasodilation and aortic stiffness in essential hypertensive patients. Eur Heart J. 2012;33:1530-1538.
-
(2012)
Eur Heart J.
, vol.33
, pp. 1530-1538
-
-
Virdis, A.1
Ghiadoni, L.2
Qasem, A.A.3
-
47
-
-
84884184229
-
Renin inhibition with aliskiren lowers circulating endothelial progenitor cells in patients with early atherosclerosis
-
Flammer AJ, Gossla M, LiaJ J, et al. Renin inhibition with aliskiren lowers circulating endothelial progenitor cells in patients with early atherosclerosis. J Hypertens. 2013;31:630-635.
-
(2013)
J Hypertens.
, vol.31
, pp. 630-635
-
-
Flammer, A.J.1
Gossla, M.2
LiaJ, J.3
|